← Back to headlines
Sangamo Therapeutics Stock Delisted from Nasdaq, Moves to OTCQB
Sangamo Therapeutics (SGMO) has been delisted from the Nasdaq exchange, with its stock now trading on the OTCQB market.
29 Apr, 14:45 — 29 Apr, 14:45
Sources
Showing 1 of 1 sources
Related Stories
Google Revises European Spam Policies to Comply With EU Antitrust Rulings
23m ago
Global Markets Await Policy Signals From Warsh’s Jackson Hole Address
26m ago
Rising Fuel Costs Push Spanish Inflation Above 4 Percent in August
45m ago
UEFA Prepares Criminal Complaint Against FIFA President Gianni Infantino
48m ago